/Investor DB

Highlight Capital

Venture capital

Nanjin · Seed–Series B

Find your way into Highlight Capital

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Highlight Capital positions itself around professionalism, stability, and innovation, focusing on deep, long-term investing in China. Over more than ten years it has built a portfolio of over 200 companies, with a notable emphasis on healthcare and life sciences (biotech, pharmaceuticals) as suggested by recent portfolio activity. The firm has achieved 30+ IPOs, indicating a track record spanning early through later stages of company development in the Chinese market.

Source: firm website, verified Aug 3, 2026.

What founders say

No founder feedback on Highlight Capital yet.

Stage
Seed–Series B
Check
$2.8M – $74M
HQ
Nanjin, CN
Instruments
Equity
Last 12 months
1 investment
Tracked investments
40
Acquisitions
1

What they invest in

from 18 of 40 portfolio companies

Healthtech ×13Biotech ×10Medical Devices ×8Hardware ×7Deep Tech ×4Digital Health ×4Advanced Manufacturing ×3Semiconductors ×3

HQs:China×7United States×4Germany×1Singapore×1

Investments · 40 tracked

founders shown can be your intro path

By year:2025 · 12020 · 12019 · 22017 · 15 dated

T-CURXt-curx.com✓ verified

T-CURX is a venture-backed biotechnology company developing autologous CAR-T cell therapies using proprietary non-viral technologies, including in vivo and bedside-manufactured CAR-T approaches based on T cell-targeted LNP delivery of Sleeping Beauty transposon vectors.

BiotechHealthtechWürzburg, DE

Michael Hudecek(Co-founder)Christoph Rader(Co-founder & Member of the Scientific Advisory Board)Ulf Grawunder(Co-founder & CEO)in

Co-investorsBioMedPartnersi&i Biotech Fund

Abogen Biosciences (艾博生物)abogenbio.comJan 2019

Abogen Biosciences is a clinical-stage biotechnology company developing RNA-based medicines, with in-house capabilities spanning the full mRNA drug development cycle including protein engineering, mRNA sequence design and synthesis, lipid nanoparticle delivery, formulation, and commercial-scale manufacturing.

BiotechDeep TechHealthtech

Co-investorsCoatue ManagementMorningside Venture Capital LimitedQiming Venture PartnersSoftBank Vision FundBoyu CapitalGL Ventures+6 more

Arthrosiarthrosi.comOct 2025 · $153M

Arthrosi Therapeutics is a clinical-stage biopharmaceutical company developing treatments for gout, an inflammatory arthritis condition.

BiotechDigital HealthMedical DevicesSan Diego, US

Litain Yeh(Co-Founder & Chief Executive Officer)inShunqi Yan(Co-Founder & Chief Operating Officer)Robert Orr(Executive Officer, Director, Promoter)Yiwei Zong(Director)Jianfeng Fang(Director)

BoardZhang Mingyuan(Director)

Co-investorsHM Venture Partners

Imagoimagobio.comin𝕏Nov 2020 · $80Macquired by Merck

A pharmaceutical company that develops medicines and vaccines, with research pipelines and clinical trials aimed at new treatments.

BiotechHealthtech

Co-investorsFrazier Life SciencesMRL Ventures FundXeraya CapitalAmgen VenturesBlackRockBlackstone Life Sciences+5 more

MCT毫厘智能mctai.cn

MCT manufactures satellite positioning and GNSS evaluation kits for automotive and robotics applications, featuring tri-band RTK receivers with automotive-grade certifications for operation in extreme temperatures.

AI & Machine LearningDeep TechHardwareRoboticsSemiconductorsChangzhou, CN

Nuevocornuevocor.comin

Nuevocor is a biotechnology company developing gene therapy treatments for cardiovascular and metabolic diseases.

BiotechDigital HealthHealthtechMedical DevicesSingapore, SG

Brian Burke(Co-Founder and Advisor)inMark Kay(Co-Founder and Advisor)Colin Stewart(Co-Founder and Advisor)Yann Chong Tan(Co-Founder and Advisor)inMonica Shah(Chief Medical Officer)inAl Gianchetti(Chief Executive Officer)in

Co-investorsAngelini VenturesKurma PartnersBoehringer Ingelheim Venture FundClavystBioSEEDS Capital

Verseau Therapeuticsverseautx.cominMar 2017

Verseau Therapeutics discovers and develops macrophage-targeting monoclonal antibodies to enhance anti-tumor immune responses in cancer patients.

AI & Machine LearningBiotechHealthtechMedical DevicesAuburndale, US

Bob Langer(Director, Promoter)Dan Anderson(Executive Officer, Director, Promoter)inTatiana NovobrantsevainIgor FeldmaninWalter Capone(Executive Officer)Christine Bunt(Executive Officer, Director)in

Co-investors20/20 HealthCare Partners LLCYonghua Capital

WuXi PharmaTechwuxiapptec.comin𝕏

WuXi AppTec is a global Contract Research, Development and Manufacturing Organization (CRDMO) that provides integrated drug development services spanning chemistry, biology discovery, preclinical testing, and clinical research across Asia, Europe, and North America.

Advanced ManufacturingBiotechEnterprise SoftwareHealthtech

Co-investorsHuangpu River CapitalVivo CapitalLegend Capital

Zentaliszentalis.comin𝕏

Zentalis is a biopharmaceutical company developing azenosertib and other pipeline assets, seeking strategic partnerships to advance drug development and expand market reach globally.

BiotechHealthtechMedical Devices

Julie Eastland(Chief Executive Officer and Director)in

BoardScott Myers(Chairperson)

Co-investorsDecheng Capital

健麾信息g-healthy.com

Shanghai General Healthy Information & Technology develops intelligent medical logistics and automation equipment, including automated pharmacy dispensing systems marketed under the CONSIS and SANTO brands, for hospitals.

Digital HealthHardwareHealthtechRoboticsShanghai, CN

康龙化成pharmaron.cnin𝕏

Pharmaron provides drug research and development services globally, supporting the discovery and development of pharmaceutical therapies through integrated capabilities across multiple geographic regions.

Advanced ManufacturingBiotechDeep TechEnterprise SoftwareHealthtechMedical DevicesBeijing, CN

楼柏良(董事长兼首席执行官 (Chairman & CEO))Lou Bailiang(Chemist, Chairman & CEO)

Co-investorsLegend Capital

归创通桥zyloxmedical.com

Zylox-Tonbridge Medical is a Chinese medical device company developing clinical solutions and products, with a focus on neurovascular and peripheral vascular interventional treatments.

HardwareHealthtechMedical DevicesHangzhou, CN

思摩尔国际smooretech.com

Smoore is an atomization technology company that develops and manufactures vaping and electronic atomization devices.

Advanced ManufacturingHardware

泰格医药tigermedgrp.com𝕏

Tigermed is a contract research organization (CRO) offering full-service clinical development support to the global biopharmaceutical and medical device industries, covering small molecules, biologics, vaccines, and medical devices.

BiotechDigital HealthHealthtechMedical DevicesHangzhou, CN

Co-investorsQiming Venture Partners

电科星拓silicon-innovation-cd.com

Chinese fabless semiconductor company developing enterprise-grade interconnect chips, including PCIe interface chips, memory interface chips and buffers, network interface chips, and clock/general interface chips.

Deep TechHardwareSemiconductorsChengdu, CN

维亚生物vivabiotech.com.cn

Drug discovery services (01873.HK)

联影医疗united-imaging.com

Medical imaging equipment company (688271.SH)

Jeffrey M Bundyin

迈瑞医疗mindray.comin

Mindray develops medical devices for hospitals and clinicians, including the N-Series patient monitors designed for high-acuity care with modular hardware and connectivity features.

HardwareHealthtechMedical Devices

鱼跃医疗yuwell.com

Medical device company (002223.SZ)

鸿翼芯kkchips.com

KK Chips designs automotive semiconductor solutions including power management, driver, and control chips for 12V and 24V automotive systems used in electric vehicles, hybrid vehicles, and commercial vehicles.

HardwareMobility & TransportationSemiconductorsGuangzhou, CN

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

GaushImago BioSciences, Inc.上海君屹亚电科技凯因科技剂泰科技千寻智能华夏英泰博瑞医药圣湘生物拓烯科技星能玄光百洋医药科美诊断科辉智药药明康德蓝色向量逻辑比特长江存储高视医疗

Exits · 1

1 acquisitions

Imagoacq. by Merck

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has Highlight Capital made?
Highlight Capital has 40 tracked investments, 1 of which have exited, including 1 dated in the last 24 months.
What stage does Highlight Capital invest at?
Highlight Capital invests at the Seed, Series A, Series B stages.
What is Highlight Capital's typical check size?
Highlight Capital typically writes checks of $2.8M – $74M.
What sectors does Highlight Capital focus on?
Highlight Capital focuses on Biotech, Crypto & Web3, Healthtech.
Where is Highlight Capital located?
Highlight Capital is headquartered in Nanjin, CN.
Who does Highlight Capital co-invest with?
Highlight Capital most often shares deals with LAV, OrbiMed, Qiming Venture Partners, among 10 tracked co-investors.

Similar investors

Featured in lists